Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve Audited Standalone & Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has informed BSE that its Board of Directors will meet on Monday, May 19, 2025 at the Registered Office. The key agenda is to consider and approve the Audited Standalone and Consolidated Financial Results for the Fourth Quarter and the financial year ended March 31, 2025. The company has also announced that the trading window will remain closed for directors, promoters, designated employees, and specified connected persons till May 21, 2025. This is a routine regulatory filing under SEBI LODR Regulation 29(1)(a) and does not itself contain the financial results.
No immediate impact on shareholders — this is a pre-result intimation. Investors should watch for the actual audited numbers when released after May 19, as Q4 and full-year FY25 results will indicate the company's full-year financial performance.